Search Results - "Stroncek, D F"

Persistence of recipient plasma cells and anti‐donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non‐myeloablative haematopoietic cell transplantation by Griffith, L. M., McCoy, J. P., Bolan, C. D., Stroncek, D. F., Pickett, A. C., Linton, G. F., Lundqvist, A., Srinivasan, R., Leitman, S. F., Childs, R. W.

“…Summary Delayed donor erythropoiesis and pure red‐cell aplasia (PRCA) complicate major‐ABO mismatched non‐myeloablative allogeneic stem‐cell transplantation…”
Get full text

The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort by Heim, K.F., Fleisher, T.A., Stroncek, D.F., Holland, S.M., Gallin, J.I., Malech, H.L., Leitman, S.F.

“…BACKGROUND: The efficacy of granulocyte transfusions in patients with HLA alloimmunization is uncertain. A flow cytometric assay using dihydrorhodamine 123…”
Get full text

immunologic aspects of poxvirus oncolytic therapy by Worschech, Andrea, Haddad, D, Stroncek, D. F, Wang, E, Marincola, Francesco M, Szalay, Aladar A

“…The concept of using replicating oncolytic viruses in cancer therapy dates to the beginning of the twentieth century. However, in the last few years, an…”
Get full text

Patient‐specific transfusion‐related acute lung injury by Muniz, M., Sheldon, S., Schuller, R. M., Young, N. S., Klein, H. G., Leitman, S. F., Stroncek, D. F.

“…Transfusion‐related acute lung injury (TRALI) is one of the leading causes of transfusion‐associated mortality. The inadvertent transfusion of neutrophil…”
Get full text

The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study by Silliman, Christopher C., Paterson, Andrew J., Dickey, William O., Stroncek, David F., Popovsky, Mark A., Caldwell, Sherrie A., Ambruso, Daniel R.

“…BACKGROUND: Transfusion‐related acute lung injury (TRALI) is clinically similar to the adult respiratory distress syndrome (ARDS) and has been linked to the…”
Get full text

Alloimmunization after granulocyte transfusions by Stroncek, D F, Leonard, K, Eiber, G, Malech, H L, Gallin, J I, Leitman, S F

“…Although granulocyte transfusions are recommended for neutropenic patients with bacterial infections that are unresponsive to antibiotic therapy, the presence…”
Get more information

Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome by Kwon, S.-W., Procter, J., Dale, J. K., Straus, S. E., Stroncek, D. F.

“…Background and Objectives  Autoimmune lymphoproliferative syndrome (ALPS), is an inherited disorder characterized by defective lymphocyte apoptosis,…”
Get full text

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells by Stroncek, D F, Clay, M E, Petzoldt, M L, Smith, J, Jaszcz, W, Oldham, F B, McCullough, J

“…Granulocyte-colony-stimulating factor (G-CSF) has been used in patients to increase the level of circulating hematopoietic progenitors. Although G-CSF has been…”
Get more information

Blood counts in healthy donors 1 year after the collection of granulocyte-colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection by Stroncek, D.F., Clay, M.E., Herr, G., Smith, J., Ilstrup, S., McCullough, J.

“…BACKGROUND: Granulocyte–colony‐stimulating factor (G–CSF)‐mobilized blood cells are being used for allogeneic transplants, but the long‐term effects of G–CSF…”
Get full text

Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors by Stroncek, D F, Clay, M E, Smith, J, Ilstrup, S, Oldham, F, McCullough, J

“…After the collection of granulocyte-colony-stimulating factor (G-CSF)-mobilized peripheral blood stem cells from healthy donors, the donor platelet counts…”
Get more information

Composition of peripheral blood progenitor cell components collected from healthy donors by Stroncek, D. F., Clay, M. E., Smith, J., Herr, G., Ilstrup, S. J., Kunkel, L. A., McCullough, J.

“…BACKGROUND: Peripheral blood progenitor cell (PBPC) components are being collected from healthy donors for allogeneic transplantation, but the quantity,…”
Get full text

Detection of HLA antibodies by using flow cytometry and latex beads coated with HLA antigens by Moses, L.A., Stroncek, D.F., Cipolone, K.M., Marincola, F.M.

“…BACKGROUND: Detection of HLA class I antibodies in sera is needed in various clinical situations. The standard method for detecting HLA class I antibodies is…”
Get full text

Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor by Stroncek, D.F., Jaszcz, W., Herr, G.P., Clay, M.E., McCullough, J.

“…BACKGROUND:Granulocyte‐colony‐stimulating factor (G‐CSF) is becoming the standard agent for mobilizing granulocytes. Most granulocyte donors are given a single…”
Get full text

Granulocyte storage and antigen stability by Chun, H., Cipolone, K., Procter, J., Stroncek, D.F.

“…BACKGROUND: Current methods for the detection of granulocyte antibodies require panels of freshly isolated cells. This makes these assays time‐consuming,…”
Get full text

Characterization of Multiple Quinine-Dependent Antibodies in a Patient With Episodic Hemolytic Uremic Syndrome and Immune Agranulocytosis by Stroncek, David F., Vercellotti, Gregory M., Hammerschmidt, Dale E., Christie, Douglas J., Shankar, Raji A., Jacob, Harry S.

“…A 23-year-old woman experienced six distinct episodes of severe combined neutropenia and thrombocytopenia. At least one of the episodes was accompanied by…”
Get full text

Determination of ABO glycosyltransferase genotypes by use of polymerase chain reaction and restriction enzymes by Stroncek, D F, Konz, R, Clay, M E, Houchins, J P, McCullough, J

“…The molecular basis of red cell ABO group antigens has been determined. The genes encoding the group A and B glycosyltransferases and a nonfunctional group O…”
Get more information

Evaluation of the gel system for ABO grouping and D typing by Langston, Melinda M., Procter, Jo Lynn, Cipolone, Karen M., Stroncek, David F.

“…BACKGROUND: The gel agglutination assay has been approved by the Food and Drug Administration as an alternative to the tube assay for the detection of red cell…”
Get full text

Analysis of the expression of NB1 antigen using two monoclonal antibodies by Stroncek, D F, Shankar, R A, Noren, P A, Herr, G P, Clement, L T

“…Neutrophil-specific antigen NB1 is expressed on neutrophil subpopulations in 97 percent of healthy individuals and is located on 56- to 64-kDa glycoprotein…”
Get more information

Prolonged neutropenia resulting from antibodies to neutrophil-specific antigen NB1 following marrow transplantation by Stroncek, D F, Shapiro, R S, Filipovich, A H, Plachta, L B, Clay, M E

“…Marrow graft failure is a significant cause of morbidity following bone marrow transplantation. A case is reported of marrow graft failure due to neutrophil…”
Get more information

Adverse reactions in patients transfused with cryopreserved marrow by Stroncek, D F, Fautsch, S K, Lasky, L C, Hurd, D D, Ramsay, N K, McCullough, J

“…Marrow is cryopreserved for use in autologous bone marrow transplants, but little is known of the incidence of reactions in patients transfused with these…”
Get more information